Efficacy and safety of montelukast in adults with asthma and allergic rhinitis

Respiratory Medicine
J Chr Virchow, C Bachert

Abstract

Several clinical studies have confirmed the effectiveness of montelukast 10mg orally in adults with both asthma and allergic rhinitis. The objective of this phase IV study was to investigate the efficacy and safety of montelukast 10mg in adults with both asthma and allergic rhinitis in a real-life setting. Data from 5855 patients (mean age: 42.8+/-15.4 years) were collected and analyzed following treatment for 4-6 weeks. Efficacy was analyzed by comparing baseline values of: general, day- and night-time improvement in asthma symptoms, need for rescue medication or inhaled corticosteroids (ICSs), general and specific improvement in allergic rhinitis symptoms, reduction in rhinitis medication use, and general and specific quality of life (QoL) improvement with values collected at the end of the observation period of 4-6 weeks. Following treatment with 10mg montelukast 86.5% (n=4547) of patients reported a strong or marked improvement in day-time asthma symptoms and 88.5% (n=4367) reported improvement in night-time symptoms. A similarly high proportion of patients had a strong or marked improvement in all symptoms of allergic rhinitis (i.e. sneezing/itching (84%), rhinorrhea (81.7%), nasal congestion (79.3%), watery eyes (78.4%) a...Continue Reading

Associated Clinical Trials

References

Jan 1, 1994·Allergy Proceedings : the Official Journal of Regional and State Allergy Societies·R J SettipaneG A Settipane
Jun 1, 1997·The Journal of Allergy and Clinical Immunology·E O Meltzer
Jan 20, 1999·The Journal of Allergy and Clinical Immunology·B P YawnA G Harris
Feb 13, 1999·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·E von Mutius
Jul 16, 2003·Allergy·J BousquetP Demoly
Mar 31, 2004·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Paul ChervinskyTheodore F Reiss
Oct 7, 2004·Current Medical Research and Opinion·George PhilipTheodore F Reiss
Jan 8, 2005·The Journal of Allergy and Clinical Immunology·Neil BarnesHelen Tate
Mar 24, 2005·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·D PriceM Thomas

❮ Previous
Next ❯

Citations

Jun 26, 2014·Annals of the American Thoracic Society·Joe K GeraldFernando D Martinez
May 15, 2010·Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology·Jayant M Pinto, Seema Jeswani
Oct 15, 2013·Clinical Interventions in Aging·Nicola ScichiloneVincenzo Bellia
Feb 28, 2009·Wiener medizinische Wochenschrift·Isabella Pali-SchöllJean Bousquet
Nov 6, 2007·The New England Journal of Medicine·Marc Peters-Golden, William R Henderson
Jul 10, 2013·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·Yves PachecoGilles Devouassoux
Feb 6, 2009·Current Medical Research and Opinion·Dana KornRudi Peché
May 8, 2015·Lung India : Official Organ of Indian Chest Society·Ritesh AgarwalSubhash Varma
Nov 8, 2008·Chest·Judah A Denburg, Paul K Keith
May 14, 2010·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Marie-Eve BoulayLouis-Philippe Boulet
May 31, 2007·Journal of the American Academy of Nurse Practitioners·Mary Lou Hayden, Catherine R Womack
Jul 23, 2011·Expert Opinion on Pharmacotherapy·Salima AmlaniRichard Andrew McIvor
Mar 20, 2008·Expert Opinion on Therapeutic Targets·Hideaki Shirasaki
Jun 28, 2014·Journal of Immunology Research·A J TheronC Feldman
Jan 30, 2007·Respiratory Medicine·Zuzana DiamantJ Christian Virchow
Aug 4, 2016·Expert Review of Respiratory Medicine·Naim KittanaAbdel-Naser Zaid
Apr 4, 2015·Allergology International : Official Journal of the Japanese Society of Allergology·Mitsuhiro OkanoKazunori Nishizaki
Sep 22, 2016·Pulmonary Pharmacology & Therapeutics·Kanchan PyasiSubhabrata Moitra
Jan 7, 2009·Therapeutic Advances in Respiratory Disease·Leif Bjermer
Feb 14, 2018·Basic & Clinical Pharmacology & Toxicology·Rahmo I FarahDaniel P Henriksen
Jun 22, 2007·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·G R Zosky, P D Sly
Apr 13, 2007·Drugs·Anjuli Nayak, Ronald B Langdon
Jun 28, 2011·Expert Review of Respiratory Medicine·Louis-Philippe Boulet, Marie-Ève Boulay
Jun 20, 2018·Molecular Medicine Reports·Ju-Hee KangMijung Yim
Jun 28, 2016·Experimental and Therapeutic Medicine·Zheng ZhuJinping Zheng
Apr 5, 2017·European Journal of Clinical Pharmacology·Malvina HoxhaAurora Bueno Cavanillas

❮ Previous
Next ❯

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.